Ravi Rao

Ravi Rao is a seasoned executive in the life sciences sector, currently serving as the Chairperson of the Board at IntegerBio and as a Venture Partner and Head of Company Creation at Samsara BioCapital since 2022. With a proven track record in company creation and scaling, Ravi Rao has previously held prominent roles including Chief Executive Officer and Director at TRex Bio, where a novel human biology platform was developed, and Chief Executive Officer and President at Complexa Inc., where corporate strategy was revamped for a successful turnaround. Ravi Rao's expertise spans kidney diseases, single-cell sequencing, and AI-powered platforms, with significant contributions to numerous companies such as Vtesse, Genocea, and MedImmune, where a robust immunology portfolio was established. Educational credentials include a PhD in Biochemistry and Molecular Biophysics from the University of Pennsylvania and a B.S. in Biology and Chemistry from the University of Wisconsin-Superior.